Back to Search
JOHN ENSLEY, M.D.
M.D.
Emergency Medicine Physician
NPI: 1326240573Individual
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
MD439959(PA)60204352(WA)
Research & Publications (20)
Effect of docetaxel on the surgical tumor microenvironment of head and neck cancer in murine models.
PMID 18645124·Arch Otolaryngol Head Neck Surg·2008
7-preclinical
Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative.
PMID 17785546·Clin Cancer Res·2007
8-other
Transoral carbon dioxide laser supraglottic laryngectomy and irradiation in stage I, II, and III squamous cell carcinoma of the supraglottic larynx: report of Southwest Oncology Group Phase 2 Trial S9709.
PMID 17938330·Arch Otolaryngol Head Neck Surg·2007
3-trial
A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
PMID 16779801·Cancer·2006
3-trial
Benefit of postoperative chemoradiotherapy for patients with unknown primary squamous cell carcinoma of the head and neck.
PMID 16933316·Head Neck·2006
8-other
Growth factor-sensitive molecular targets identified in primary and metastatic head and neck squamous cell carcinoma using microarray analysis.
PMID 16266819·Oral Oncol·2006
8-other
Cellular DNA content parameters as prognostic indicators in human astrocytomas.
PMID 15690121·J Neurooncol·2005
4-observational
Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry.
PMID 15695121·Oral Oncol·2005
8-other
Spectra of antinuclear antibodies in patients with squamous cell carcinoma of the lung and of the head and neck.
PMID 15734219·Cancer Detect Prev·2005
4-observational
An in vivo evaluation of docetaxel delivered intratumorally in head and neck squamous cell carcinoma.
PMID 15897421·Arch Otolaryngol Head Neck Surg·2005
4-observational
Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.
PMID 15908667·J Clin Oncol·2005
3-trial
Docetaxel associated pathways in cisplatin resistant head and neck squamous cell carcinoma: a pilot study.
PMID 16319602·Laryngoscope·2005
4-observational
Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial.
PMID 15625363·J Clin Oncol·2005
3-trial
Uncoupling of epidermal growth factor-dependent proliferation and invasion in a model of squamous carcinoma progression.
PMID 15935723·Oral Oncol·2005
7-preclinical
Microsatellite alterations in african americans with head and neck cancer.
PMID 15475792·Laryngoscope·2004
4-observational
Detection of plasminogen activators in oral cancer by laser capture microdissection combined with zymography.
PMID 15509494·Oral Oncol·2004
8-other
Enhancement of Ad-p53 therapy with docetaxel in head and neck cancer.
PMID 15510008·Laryngoscope·2004
7-preclinical
Pseudoaneuploid subpopulations detected in normal upper aerodigestive tract mucosa consistent with physiological apoptosis in normally differentiating squamous mucosa.
PMID 15523439·Otolaryngol Head Neck Surg·2004
8-other
Correlation of histopathological variants, cellular DNA content, and clinical outcome in adenoid cystic carcinoma of the salivary glands.
PMID 15523442·Otolaryngol Head Neck Surg·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 21431 ROYAL ANNE RD
BOTHELL, WA 98021 - Phone
- (936) 577-9456
Quick Facts
- NPI
- 1326240573
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile